Platelet interaction with activated endothelium: Mechanistic insights from microfluidics

Blood

Volumn 130, Issue 26, 2017, Pages 2819-2828

  Coenen, Daniëlle M ^a   Mastenbroek, Tom G ^a   Cosemans, Judith M E M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIVALIRUDIN; CD36 ANTIGEN; CYCLOOXYGENASE 1; DESMOPRESSIN; DIPYRIDAMOLE; GLYCOPROTEIN; GLYCOPROTEIN IB; HEPARIN; HIRUDIN; INTERCELLULAR ADHESION MOLECULE 1; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PLATELET GLYCOPROTEIN IX; PLATELET GLYCOPROTEIN V; PODOPLANIN; THROMBIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BLOOD; BLOOD CLOTTING; BLOOD FLOW; BLOOD SAMPLING; CAPILLARY ENDOTHELIAL CELL; CELL INTERACTION; CELL SURFACE; DRUG EFFECT; ENDOTHELIUM; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUVEC CELL LINE; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPH VESSEL; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; CELL COMMUNICATION; METABOLISM; PHYSIOLOGY; PROCEDURES; RECEPTOR CROSS-TALK; TRENDS; VASCULAR ENDOTHELIUM;

BLOOD PLATELETS; CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; HUMANS; MICROFLUIDICS; RECEPTOR CROSS-TALK; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 85039961113     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-04-780825     Document Type: Review

References (86)

1. Smolenski A. Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost. 2012;10(2):167-176.
2. Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327-358.
3. Weiss DJ. Comparative physiology of platelets from different species. In: Rao FHR, ed. Handbook of Platelet Physiology and Pharmacology. New York, NY: Springer;1999: 379-393.
4. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res. 2013;99(2): 342-352.
5. de Witt SM, Verdoold R, Cosemans JM, Heemskerk JW. Insights into platelet-based control of coagulation. Thromb Res. 2014; 133(suppl 2):S139-S148.
6. de Witt SM, Nergiz-Ünal N, Feijge MA, et al. Genes in arterial thrombus formation: a comparison of in vivo and in vitro studies. J Thromb Haemost. 2013;11(suppl 2):352-353.
7. Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013; 11(1):2-16.
8. Kalz J, ten Cate H, Spronk HM. Thrombin generation and atherosclerosis. J Thromb Thrombolysis. 2014;37(1):45-55.
9. Mastenbroek TG, van Geffen JP, Heemskerk JW, Cosemans JM. Acute and persistent platelet and coagulant activities in atherothrombosis. J Thromb Haemost. 2015;13(suppl 1):S272-S280.
10. Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest. 1997;100(8): 2085-2093.
11. Santoso S, Sachs UJ, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196(5):679-691.
12. Wang Y, Sakuma M, Chen Z, et al. Leukocyte engagement of platelet glycoprotein Iba via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation. 2005; 112(19):2993-3000.
13. Zhao Z, Vajen T, Karshovska E, et al. Deletion of junctional adhesion molecule A from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice. J Cell Mol Med. 2017;21(8):1523-1531.
14. Quinn KL, Henriques M, Tabuchi A, et al. Human neutrophil peptides mediate endothelial-monocyte interaction, foam cell formation, and platelet activation. Arterioscler Thromb Vasc Biol. 2011; 31(9):2070-2079.
15. von Hundelshausen P, Koenen RR, Sack M, et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105(3):924-930.
16. van der Vorst EP, Döring Y, Weber C. Chemokines. Arterioscler Thromb Vasc Biol. 2015;35(11):e52-e56.
17. Koenen RR. The prowess of platelets in immunity and inflammation. Thromb Haemost. 2016;116(4): 605-612.
18. Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4): 248-261.
19. Westein E, de Witt S, Lamers M, Cosemans JM, Heemskerk JW. Monitoring in vitro thrombus formation with novel microfluidic devices. Platelets. 2012;23(7):501-509.
20. McCarty OJ, Ku D, Sugimoto M, King MR, Cosemans JM, Neeves KB; Subcommittee on Biorheology. Dimensional analysis and scaling relevant to flow models of thrombus formation: communication from the SSC of the ISTH. J Thromb Haemost. 2016;14(3):619-622.
21. Gresele P, Arnout J, Deckmyn H, Vermylen J. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity. Thromb Haemost. 1986;55(1):12-18.
22. Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW. Multiple ways to switch platelet integrins on and off. J Thromb Haemost. 2008; 6(8):1253-1261.
23. Rataj D, Werwitzke S, Haarmeijer B, et al. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation. Xenotransplantation. 2016;23(2):117-127.
24. Kirchhofer D, Tschopp TB, Hadváry P, Baumgartner HR. Endothelial cells stimulated with tumor necrosis factor-a express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest. 1994;93(5): 2073-2083.
25. Harris DG, Benipal PK, Cheng X, Burdorf L, Azimzadeh AM, Pierson RN III. Four-dimensional characterization of thrombosis in a live-cell, shear-flow assay: development and application to xenotransplantation. PLoS One. 2015;10(4): e0123015.
26. Ciciliano JC, Sakurai Y, Myers DR, et al. Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach. Blood. 2015;126(6):817-824.
27. Roest M, Reininger A, Zwaginga JJ, King MR, Heemskerk JW; Biorheology Subcommittee of the SSC of the ISTH. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J Thromb Haemost. 2011;9(11):2322-2324.
28. Van Kruchten R, Cosemans JM, Heemskerk JW. Measurement of whole blood thrombus formation using parallel-plate flow chambers – a practical guide. Platelets. 2012;23(3):229-242.
29. Neeves KB, McCarty OJ, Reininger AJ, Sugimoto M, King MR; Biorheology Subcommittee of the SSC of the ISTH. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J Thromb Haemost. 2014;12(3):418-420.
30. Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA. Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest. 2016;126(3):821-828.
31. Frueh J, Maimari N, Homma T, et al. Systems biology of the functional and dysfunctional endothelium. Cardiovasc Res. 2013;99(2): 334-341.
32. Resnick N, Yahav H, Shay-Salit A, et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003; 81(3):177-199.
33. Romo GM, Dong JF, Schade AJ, et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med. 1999; 190(6):803-814.
34. Jain A, van der Meer AD, Papa AL, et al. Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomed Microdevices. 2016;18:73.
35. Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002; 196(7):887-896.
36. Gidlof O, van der Brug M, Ohman J, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood. 2013;121(19):3908-3917.
37. Laffont B, Corduan A, Plé H, et al. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood. 2013;122(2):253-261.
38. Aird WC. Endothelium and haemostasis. Hamostaseologie. 2015;35(1):11-16.
39. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002; 100(12):4033-4039.
40. Sylman JL, Artzer DT, Rana K, Neeves KB. A vascular injury model using focal heat-induced activation of endothelial cells. Integr Biol. 2015; 7(7):801-814.
41. Thijssen VL, Hulsmans S, Griffioen AW. The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol. 2008;172(2): 545-553.
42. Romaniuk MA, Croci DO, Lapponi MJ, et al. Binding of galectin-1 to aIIbb3 integrin triggers “outside-in” signals, stimulates platelet activation, and controls primary hemostasis. FASEB J. 2012; 26(7):2788-2798.
43. Theilmeier G, Michiels C, Spaepen E, et al. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood. 2002;99(12): 4486-4493.
44. 3 on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113(7):1589-1597.
45. Zheng Y, Chen J, López JA. Flow-driven assembly of VWF fibres and webs in in vitro microvessels. Nat Commun. 2015;6:7858.
46. Galbusera M, Buelli S, Gastoldi S, et al. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation. Xenotransplantation. 2005; 12(2):110-120.
47. Kuckleburg CJ, Yates CM, Kalia N, et al. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res. 2011; 91(1):134-141.
48. Calmer S, Ferkau A, Larmann J, et al. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro. Platelets. 2014;25(1):8-15.
49. Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med. 2000;191(8): 1413-1422.
50. da Costa Martins P, García-Vallejo JJ, van Thienen JV, et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol. 2007;27(5): 1023-1029.
51. Terrisse AD, Puech N, Allart S, et al. Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost. 2010;8(12): 2810-2819.
52. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.
53. Rivera-Nieves J, Burcin TL, Olson TS, et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med. 2006; 203(4):907-917.
54. Massberg S, Schürzinger K, Lorenz M, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112(8): 1180-1188.
55. Coller BS. aIIbb3: structure and function. J Thromb Haemost. 2015;13(suppl 1):S17-S25.
56. Dardik R, Savion N, Kaufmann Y, Varon D. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer. 1998;77(12): 2069-2075.
57. Reininger AJ, Korndörfer MA, Wurzinger LJ. Adhesion of ADP-activated platelets to intact endothelium under stagnation point flow in vitro is mediated by the integrin aIIbb3. Thromb Haemost. 1998;79(5):998-1003.
58. Tull SP, Anderson SI, Hughan SC, Watson SP, Nash GB, Rainger GE. Cellular pathology of atherosclerosis: smooth muscle cells promote adhesion of platelets to cocultured endothelial cells. Circ Res. 2006;98(1):98-104.
59. Schulz C, Schäfer A, Stolla M, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation. 2007;116(7): 764-773.
60. Tsai M, Kita A, Leach J, et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest. 2012;122(1):408-418.
61. Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor–results from patients with acute myocardial infarction and healthy controls. Thromb Haemost. 2000;83(2):217-223.
62. vb3 integrin, and GPIba. J Exp Med. 1998;187(3):329-339.
63. 3 mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96(6):1809-1818.
64. Karunarathne W, Ku CJ, Spence DM. The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integr Biol. 2009;1(11-12):655-663.
65. Lagadec P, Dejoux O, Ticchioni M, et al. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow. Blood. 2003;101(12): 4836-4843.
66. Nergiz-Ünal R, Lamers MM, Van Kruchten R, et al. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. J Thromb Haemost. 2011;9(9): 1835-1846.
67. Kuijpers MJ, de Witt S, Nergiz-Ünal R, et al. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Arterioscler Thromb Vasc Biol. 2014;34(6): 1187-1192.
68. Bonnefoy A, Daenens K, Feys HB, et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood. 2006;107(3):955-964.
69. Isenberg JS, Romeo MJ, Yu C, et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood. 2008; 111(2):613-623.
70. Roberts W, Magwenzi S, Aburima A, Naseem KM. Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. Blood. 2010;116(20):4297-4306.
71. Navarro-Núñez L, Pollitt AY, Lowe K, Latif A, Nash GB, Watson SP. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling. Thromb Haemost. 2015; 113(5):1109-1120.
72. Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost. 2009;102(6): 1149-1156.
73. Ivanciu L, Stalker TJ. Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo. J Thromb Haemost. 2015;13(11):1949-1959.
74. Zheng Y, Chen J, Craven M, et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc Natl Acad Sci USA. 2012; 109(24):9342-9347.
75. Westein E, van der Meer AD, Kuijpers MJ, Frimat JP, van den Berg A, Heemskerk JW. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc Natl Acad Sci USA. 2013;110(4):1357-1362.
76. Costa PF, Albers HJ, Linssen JEA, et al. Mimicking arterial thrombosis in a 3D-printed microfluidic in vitro vascular model based on computed tomography angiography data. Lab Chip. 2017;17(16):2785-2792.
77. de Witt SM, Swieringa F, Cavill R, et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun. 2014;5:4257.
78. Payne H, Ponomaryov T, Watson SP, Brill A. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Blood. 2017;129(14): 2013-2020.
79. Edelstein LC. The role of platelet microvesicles in intercellular communication. Platelets. 2017; 28(3):222-227.
80. Chappell D, Brettner F, Doerfler N, et al. Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion: an animal study. Eur J Anaesthesiol. 2014;31(9):474-481.
81. Zhang YS, Davoudi F, Walch P, et al. Bioprinted thrombosis-on-a-chip. Lab Chip. 2016;16(21): 4097-4105.
82. Mastenbroek TG, Feijge MA, Kremers RM, et al. Platelet-associated matrix metalloproteinases regulate thrombus formation and exert local collagenolytic activity. Arterioscler Thromb Vasc Biol. 2015;35(12):2554-2561.
83. de Groot PG, Sixma JJ. Perfusion chambers. In: Michelson AD, ed. Platelets. San Diego, CA: Academic Press; 2002:347-356
84. Sakariassen KS, Orning L, Turitto VT. The impact of blood shear rate on arterial thrombus formation. Future Sci OA. 2015;1(4):FSO30.
85. Tanahashi N, Fukuuchi Y, Tomita M, et al. Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa. Neurosci Lett. 2001;301(1):33-36.
86. Tomita Y, Tanahashi N, Tomita M, et al. Role of platelet glycoprotein IIb/IIIa in ADP-activated platelet adhesion to aortic endothelial cells in vitro: observation with video-enhanced contrast microscopy. Clin Hemorheol Microcirc. 2001; 24(1):1-9.